Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody
Kar Muthumani(The Wistar Institute), David B. Weiner(The Wistar Institute), Elizabeth K. Duperret(The Wistar Institute), Sangya Agarwal(Amgen (United States)), Kenneth E. Ugen(University of South Florida), Veronica L. Scott(University of Pennsylvania), Liron Marnin(University of Pennsylvania), Niranjan Y. Sardesai(Io Therapeutics (United States)), Emma L. Reuschel(The Wistar Institute), Kimberly A. Kraynyak(Inovio Pharmaceuticals (United States)), Alfredo Perales‐Puchalt(The Wistar Institute), Megan C. Wise(Princess Alexandra Hospital), Faraz I. Zaidi(The Wistar Institute), J. Joseph Kim(Inovio Pharmaceuticals (United States)), Sagar B. Kudchodkar(The Wistar Institute), Hyeree Choi(The Wistar Institute)
Cited by 42
Related Papers
ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis
|Cell|2015|921
Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction
|Cancer Discovery|2020|297
Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery
|The Journal of Infectious Diseases|2013|197